Major companies operating in the kedrab market are Kamada Ltd. and Kedrion Biopharma Inc.. North America was the largest region in the kedrab market in 2024. Asia-Pacific is expected to be the fastest ...

Please provide your email address to receive an email when new articles are posted on . Sublingual delivery of epinephrine achieved pharmacokinetic and pharmacodynamic results that were comparable ...

Niagen Bioscience, Inc. (Nasdaq: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine ...

The Autoinjectors Market is expected to witness a growth rate of 14-16% by 2028. The key factors driving the market are the ...

NAD+ is considered beneficial for various cellular reactions that benefit your healthspan. It may also support more ...

The global canine flu therapeutics market is on a robust growth trajectory, projected to expand from USD 2,168.2 million in 2025 to an impressive USD 3,179.2 million by 2035. With a compound annual ...

K-State beef cattle veterinarian Bob Larson offers safety advice for minimizing exposure when administering vaccines to ...

Achieving the best results with vaccines requires using the correct syringes and needles, good management practices and ...

Q1 2025 Earnings Call Transcript May 8, 2025 Crinetics Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 ...

Net cash used in operating and investing activities was $53.4 million in the first quarter of 2025; quarter-end cash and restricted cash position was $418.8 million Topline results expected ...